Gene · 624
Papers3,739
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,739
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Kinin B2 Receptor Signaling in Astrocyte-driven Neuroinflammation. | Cell Mol Neurobiol | 2026 | 41612092 | PubTator, text mining | PubMed |
| Altitude hypoxia and hypoxemia: pathogenesis and management. | Signal Transduct Target Ther | 2026 | 41571626 | PubTator, text mining | PubMed |
| Use of endotracheal epinephrine for refractory unanticipated post-intubation bronchospasm. | BMJ Case Rep | 2026 | 41554617 | PubTator, text mining | PubMed |
| Non-peptide bradykinin B2 receptor ligands possessing the substituted quinolinyl moiety: Pharmacological properties and prospective clinical uses. | Peptides | 2026 | 41548609 | PubTator, text mining | PubMed |
| Pharmacological characterization and neuroprotective efficacy of ZHB103, a novel long-acting rhKLK1. | Neurotherapeutics | 2026 | 41547653 | PubTator, text mining | PubMed |
| FLIPs: Genetically encoded molecular biosensors for functional imaging of cell signaling by linear dichroism microscopy. | Sci Adv | 2026 | 41544164 | PubTator, text mining | PubMed |
| Organ cross-talk: molecular mechanisms, biological functions, and therapeutic interventions for diseases. | Signal Transduct Target Ther | 2026 | 41491917 | PubTator, text mining | PubMed |
| Compartment-specific activation of kinin B1 and B2 receptors drives the production of vasoactive and inflammatory mediators during SARS-CoV-2 infection. | Immunol Lett | 2026 | 41422848 | PubTator, text mining | PubMed |
| Effect of the Arg16Gly β2-Adrenergic Receptor Polymorphism on Long-Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype-Stratified, Multicenter Study. | Allergy | 2026 | 40985517 | PubTator, text mining | PubMed |
| Ultrasound-assisted gram-scale synthesis of nano-tubular ag-MOF and its hybridization with yellow/green carbon quantum dots: membrane-based turn-on fluorescence recognition for procaterol. | Spectrochim Acta A Mol Biomol Spectrosc | 2026 | 40839951 | PubTator, text mining | PubMed |
| Immuno-neural mechanisms in gastrointestinal tumorigenesis: bridging inflammation, neural regulation, and therapeutic innovation. | Front Immunol | 2025 | 41799687 | PubTator, text mining | PubMed |
| Kinin receptors in adipose tissue: drivers of inflammation and metabolic dysfunction in obesity. | Inflamm Res | 2025 | 41345311 | PubTator, text mining | PubMed |
| Efficacy of different drug treatment regimens in acute asthma in children in North China: A meta-analysis. | Medicine (Baltimore) | 2025 | 41239599 | PubTator, text mining | PubMed |
| Kallikrein-kinin system as a potential target for the treatment of intervertebral disc degeneration. | Eur J Med Res | 2025 | 41204253 | PubTator, text mining | PubMed |
| Bradykinin-bradykinin 2 receptor and oxidative stress. | Ann Med | 2025 | 41178473 | PubTator, text mining | PubMed |
| Developing accessible and affordable tests to support mpox immunosurveillance and vaccine studies. | Emerg Microbes Infect | 2025 | 41099136 | PubTator, text mining | PubMed |
| Pharmacogenomic biomarkers of ACE inhibitor-induced cough in a multi-ethnic UAE cohort. | Front Pharmacol | 2025 | 41079724 | PubTator, text mining | PubMed |
| The downregulation of B2R inhibits spiral artery remodeling by reducing the autophagy of trophoblast cells. | Placenta | 2025 | 41076744 | PubTator, text mining | PubMed |
| Multi-omics integration uncovers key transcriptional regulators in triple-negative breast cancer spatial heterogeneity. | Front Genet | 2025 | 40969325 | PubTator, text mining | PubMed |
| Trastuzumab Cardiotoxicity: Mechanism and Management. | Biol Pharm Bull | 2025 | 40887295 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/624/papers?page=2